BEHAVIORAL TREATMENT OF RAYNAUD'S PHENOMENON
BEHAVIORAL TREATMENT OF RAYNAUD'S PHENOMENON
批准号:
3341613
负责人:
ROBERT R FREEDMAN
金额:
$10.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 1988-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In our current investigations we first verified that the significant
symptom reductions reported by Raynaud's disease patients given temperature
feedback (TEMP) and temperature feedback under cold stress (TEMPCS) were
maintained over a 3-year, follow-up period and that the TEMPCS group
maintained its superiority over the TEMP group. We then demonstrated that
a beta-adrenergic vasodilating mechanism is active during temperature
feedback and that capillary blood flow is significantly increased during
feedback in patients but not normals. We now propose to determine if any
of the effects of temperature feedback are neurally mediated, to see if
these effects generalize to the lower extremities, and to determine if
increased capillary blood flow is responsible for the long-term effects of
TEMP and TEMPCS treatment and for the continued superiority of the latter.
If TEMPCS treatment promotes increased capillary blood flow over extended
time periods, it may be beneficial in the treatment of Raynaud's phenomenon
in scleroderma. We propose to test this in a controlled study, using an
isotope clearance procedure implemented during the past year.
Recently, an increased number of Alpha2 receptors has been reported on the
platelets of patients with idiopathic Raynaud's disease. We, therefore,
propose to examine finger vascular responses to arterial infusion of
clonidine, a selective Alpha2 agonist. Also, evidence exists that
norepinephrine (NE) released from sympathetic nerve endings may produce
vascular effects different from those of exogenously administered
catecholamines or synthetic agonists. Tyramine acts by liberating stored
NE from adrenergic nerve endings and we propose to compare the digital
vascular responses to tyramine of Raynaud's disease patients and matched
normals. Finally, research on the etiology of Raynaud's disease has been
hindered by the inability to produce attacks in the laboratory. Recently,
Wise et al. reported induction of attacks in 100% of 14 Raynaud's patients
using total body cooling. We propose to employ this procedure to examine
the role of the sympathetic nerves in vasospastic attacks using selective
digital nerve blocks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
-
批准号:8120340
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELS
-
批准号:8120338
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
ADMINISTRATION AND DATABASE
-
批准号:8120341
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
STATISTICAL GENETICS AND TREATMENT ANALYSIS
-
批准号:8120342
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN CHRNA7 MODELS IN MICE
-
批准号:8120339
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
NICOTINIC CHOLINERGIC RECEPTOR AGONISTS
-
批准号:8120343
-
项目类别:
-
资助金额:$11.89万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:8120335
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
REGULATION OF CHRNA7 EXPRESSION
-
批准号:8120337
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN PERINATAL INTERVENTION
-
批准号:8120336
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:8515782
-
项目类别:
-
资助金额:$1.71万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
REGULATION OF CHRNA7 EXPRESSION
-
批准号:7752182
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
STATISTICAL GENETICS AND TREATMENT ANALYSIS
-
批准号:7752199
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
ADMINISTRATION AND DATABASE
-
批准号:7752198
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN CHRNA7 MODELS IN MICE
-
批准号:7752195
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN PERINATAL INTERVENTION
-
批准号:7752181
-
项目类别:
-
资助金额:$27.79万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELS
-
批准号:7752190
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
NICOTINIC CHOLINERGIC RECEPTOR AGONISTS
-
批准号:7752204
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
-
批准号:7752197
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:7752180
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MENOPAUSAL HOT FLASHES
-
批准号:7349398
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2006
-
负责人:ROBERT R FREEDMAN
-
依托单位:
海外基金